Track 09 of 9
Pain Medicine
Acute postoperative pain and chronic pain interventions.
Pain medicine has been reshaped by the opioid crisis, opioid-sparing perioperative pathways, and a growing armamentarium of interventional and neuromodulation techniques. GCSA 2027 will cover transitional pain services to prevent persistent postsurgical pain, multimodal regimens combining acetaminophen, NSAIDs, gabapentinoids (used judiciously), ketamine, and lidocaine infusions, and the role of suzetrigine (Nav1.8 inhibitor) as a non-opioid acute pain option. Interventional sessions address dorsal root ganglion stimulation, high-frequency and closed-loop spinal cord stimulation, radiofrequency ablation for facet and genicular pain, and intrathecal drug delivery.
Focus areas
- Transitional pain services and prevention of persistent postsurgical pain
- Suzetrigine (Nav1.8) and emerging non-opioid acute pain agents
- Ketamine and lidocaine infusions in opioid-sparing pathways
- Dorsal root ganglion and closed-loop spinal cord stimulation
- Radiofrequency ablation: facet, genicular, and SI joint targets
- Intrathecal drug delivery and cancer pain management
- Cannabinoids, psychedelics, and evolving evidence in chronic pain